Nubiyota

MICROBIOME THERAPY EVOLUTION

Pioneering the Next Generation of Microbiome Therapeutics

Restoring Equilibrium,
Restoring Health

NuBiyota is a microbiome therapeutics company focused on the development of novel microbiota-based drugs to restore crucial gut equilibrium. An imbalance in this crucial ecosystem is associated with infections, chronic disease and even neurological dysfunction.

NuBiyota is developing a new class of microbiome therapeutics, with multi-strain microbiota candidates for effective microbiota diversity restoration to suppress flares or promote remission in numerous indications.

NuBiyota’s Microbial Ecosystem Therapeutics (MET) Technology

NuBiyota’s Microbial Ecosystem Therapeutics (MET) technology combines microbiota derived from an individual “super donor” with a unique culturing process for optimal results.

Super Donor

High Efficacy

Complete Microbiome Restoration

Consistency and Reproducibility

Our Pipeline

Using its proprietary Microbial Ecosystem Therapeutics technology, and GMP standard production capabilities, NuBiyota has 4 clinical stage candidates in various stages of development and testing.
0
Years of R&D
0
Candidates
0
Publications